New developments in locally advanced nonsmall cell lung cancer

Locally advanced nonsmall cell lung cancer, due to its varying prognosis, is grouped according to TNM stage IIIA, IIIB and IIIC. Developments over the last 3 years have been focused on the integration of immunotherapy into the combination treatment of a locally definitive therapy (surgery or radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Rudolf M., Kauffmann-Guerrero, Diego, Hoffmann, Hans, Flentje, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488500/
https://www.ncbi.nlm.nih.gov/pubmed/33952600
http://dx.doi.org/10.1183/16000617.0227-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488500/
https://www.ncbi.nlm.nih.gov/pubmed/33952600
http://dx.doi.org/10.1183/16000617.0227-2020

Ejemplares similares